"10.1371_journal.pone.0103883","plos one","2014-08-19T00:00:00Z","Antonio Marchetti; Maela Del Grammastro; Lara Felicioni; Sara Malatesta; Giampaolo Filice; Irene Centi; Tommaso De Pas; Armando Santoro; Antonio Chella; Alba Ariela Brandes; Paola Venturino; Franco Cuccurullo; Lucio Crin√≤; Fiamma Buttitta","Center of Predictive Molecular Medicine, Center of Excellence on Aging, University-Foundation, Chieti, Italy; Oncological and Cardiovascular Molecular Medicine Unit, Center of Excellence on Aging, University-Foundation, Chieti, Italy; Hospital SS Annunziata, Pathology Unit, Chieti, Italy; Department of Medicine, European Institute of Oncology, Milan, Italy; Department of Oncology, Humanitas Cancer Center IRCCS, Rozzano, Italy; Cardiothoracic Department, University of Pisa, Pisa, Italy; Department of Medical Oncology, Bellaria-Maggiore Hospital, Azienda USL of Bologna, Bologna, Italy; Roche S.p.A., Monza, Italy; Department of Medical Oncology, Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy","Conceived and designed the experiments: AM FB. Performed the experiments: MDG LF SM GF IC. Analyzed the data: AM MDG LF GF FB. Contributed reagents/materials/analysis tools: TDP AS AC AAB LC. Wrote the paper: AM FB. Supervision: AM PV FC FB.","This study was partly funded by Roche S.p.A., the employer of Paola Venturino. The CellSearch system tested in this study is a commercial tool (Veridex LLC). There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","08","Antonio Marchetti","AM",14,TRUE,2,5,5,2,TRUE,TRUE,FALSE,0,NA,FALSE
